Monitor whether Rosalind Advisors files a Schedule 13D (activist intent) or continues to increase its position. The 9.1% stake is below the 10% threshold that would require more detailed disclosure, but any further accumulation or change in filing status would signal a shift in strategy.
MDWD drugs
MDWD drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+1- T+0 · Nov 13 $12.90entry
- T+1 · 20h ago +5.04%α +6.95% · $13.55
- T+5 · in 3d Pending
- T+20 · in 27d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Rosalind Advisors and related entities filed an amended Schedule 13G disclosing beneficial ownership of 1,312,319 shares (9.1% of outstanding common stock) of MediWound Ltd., consisting of 1,149,054 common shares and 163,265 shares issuable upon exercise of warrants. The filing updates a prior 13G from May 2026, but no prior stake figures are available in the provided documents for comparison; the stake appears to be a new position or an increase from a previously unreported level.
Key Financial Metrics
Key Facts
- Rosalind Advisors, Inc., Rosalind Master Fund L.P., Steven Salamon, and Gilad Aharon jointly filed an amended Schedule 13G on November 13, 2026.
- The group reports beneficial ownership of 1,312,319 shares, representing 9.1% of MediWound's 14,210,217 common shares outstanding as of November 5, 2026.
- The stake comprises 1,149,054 common shares and 163,265 shares issuable upon exercise of warrants (subject to a 9.99% blocker provision).
- The filing is an amendment to a prior Schedule 13G filed on May 15, 2026; no prior stake percentage or share count is provided in the current documents for comparison.
- The filers certify passive intent under Rule 13d-1(d), disclaiming any purpose to change or influence control.
Financial Impact
9.1% beneficial ownership stake valued at approximately $18.1M based on $199M market cap
Risk Factors
- The filing does not provide prior stake data for comparison, so the direction of change (increase, decrease, or new position) cannot be determined from the documents alone.
- The 163,265 warrant shares are subject to a blocker provision limiting exercise to 9.99% beneficial ownership, capping potential dilution impact.
- As a passive 13G filer, Rosalind Advisors disclaims activist intent, but any future conversion to a 13D would indicate a more active stance.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G/A Filing (Primary) | 0001622627-26-000029 |
| Document: 0001622627-26-000029-index-headers.html | 0001622627-26-000029 |
| Document: 0001622627-26-000029-index.html | 0001622627-26-000029 |
| Document: 0001622627-26-000029.txt | 0001622627-26-000029 |
Track record
13 reports on MDWD
6 of 7 bullish or bearish reports moved the stock their way by T+5. Best: +20.80% at T+60 after the Mar 5, 2026 report. 7 of 8 went positive at some point.
Filters
- Nov 13, 20263d ago SC 13G/A Neutral 3/10 Viewing Entry $12.90 Now $13.55 +5.04% settles Nov 20
- Nov 12, 20264d ago 6-K Bearish 6/10 No price data
- Nov 12, 20264d ago Press Release Bearish 6/10 Entry $12.97 Now $13.55 −4.47% settles Nov 19
- Nov 5, 202611d ago 6-K Bearish 6/10 Entry $13.33 to $12.97 Now $13.55 −1.65% ▲ +2.70% +5.99% vs SPY
- Nov 5, 202611d ago 424B5 Bearish 5/10 Entry $13.33 to $12.97 Now $13.55 −1.65% ▲ +2.70% +5.99% vs SPY
- Nov 3, 202613d ago 424B5 Bearish 5/10 Entry $14.20 to $13.82 Now $13.55 +4.58% ▲ +2.68% +1.76% vs SPY
- Sep 22, 20267w ago Press Release Bullish 4/10 Entry $13.95 to $13.80 Now $13.55 −2.87% ▼ −1.08% +0.11% vs SPY
- Jun 2, 202623w ago Insider Cluster Bullish 4/10 Entry $13.76 to $14.30 Now $13.55 −1.53% ▲ +3.92% +6.89% vs SPY
- May 27, 202624w ago Press Release Bearish 5/10 Entry $14.33 to $13.73 Now $13.55 +5.44% ▲ +4.19% +4.66% vs SPY
- May 7, 202627w ago Press Release Neutral 1/10 Entry $17.27 to $16.25 Now $13.55 −21.54% ▼ −5.91% −7.41% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers